Stübs F, Mergel F, Koch M, Dietl A, Schulmeyer C, Adler W, Geppert CI, Hartmann A, Knöll A, Beckmann M, Gaß P, Mehlhorn G (2022)
Publication Type: Journal article
Publication year: 2022
DOI: 10.1007/s00404-022-06815-7
Purpose: The aims of the present study were to evaluate the development of untreated cervical intraepithelial neoplasia (CIN) 3 during pregnancy and to assess persistence, progression, and regression rates postpartum to identify factors associated with regression. Methods: In a tertiary gynecology and obstetrics department, a total of 154 pregnant women with CIN 3 were treated in the dysplasia unit. The follow-up findings were analyzed retrospectively on the basis of histological, cytological, and human papillomavirus (HPV) testing of 154 pregnant women confirmed as having CIN 3 in colposcopically guided biopsies. Results: The rates of persistence, regression, and progression of CIN 3 in these women were 76.1%, 20% and 3.2%, respectively. Data for the delivery mode was available for 126 women. The rate of regression was almost twice as high with vaginal delivery as with cesarean section, at 27.4 vs. 15.2%, whereas the rate of progression was lower with vaginal delivery, at 2.7 vs. 6.5%. Conclusion: The rate of persistence of CIN observed in this study is comparable to that reported in other studies. The study provides strong evidence for greater regression among women who have vaginal deliveries. Careful work-up is recommended postpartum for this group of women in order to rule out persistent CIN 3 or invasive disease.
APA:
Stübs, F., Mergel, F., Koch, M., Dietl, A., Schulmeyer, C., Adler, W.,... Mehlhorn, G. (2022). Cervical intraepithelial neoplasia grade 3: development during pregnancy and postpartum. Archives of Gynecology and Obstetrics. https://dx.doi.org/10.1007/s00404-022-06815-7
MLA:
Stübs, Frederik, et al. "Cervical intraepithelial neoplasia grade 3: development during pregnancy and postpartum." Archives of Gynecology and Obstetrics (2022).
BibTeX: Download